Bayer AG (BAYRY)
7.26
-0.11
(-1.49%)
USD |
OTCM |
Apr 24, 16:00
Bayer Cash and Short Term Investments (Quarterly): 11.70B for Dec. 31, 2023
Cash and Short Term Investments (Quarterly) Chart
Historical Cash and Short Term Investments (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 11.70B |
September 30, 2023 | 9.850B |
June 30, 2023 | 8.292B |
March 31, 2023 | 8.696B |
December 31, 2022 | 10.89B |
September 30, 2022 | 8.919B |
June 30, 2022 | 8.559B |
March 31, 2022 | 9.145B |
December 31, 2021 | 8.762B |
September 30, 2021 | 9.533B |
June 30, 2021 | 7.733B |
March 31, 2021 | 10.92B |
December 31, 2020 | 14.62B |
September 30, 2020 | 18.24B |
June 30, 2020 | 6.420B |
March 31, 2020 | 5.571B |
December 31, 2019 | 6.053B |
September 30, 2019 | 6.077B |
June 30, 2019 | 4.789B |
March 31, 2019 | 5.518B |
December 31, 2018 | 5.969B |
September 30, 2018 | 7.494B |
June 30, 2018 | 7.558B |
March 31, 2018 | 15.59B |
December 31, 2017 | 10.91B |
Date | Value |
---|---|
September 30, 2017 | 13.69B |
June 30, 2017 | 11.45B |
March 31, 2017 | 9.496B |
December 31, 2016 | 5.734B |
September 30, 2016 | 3.811B |
June 30, 2016 | 2.189B |
March 31, 2016 | 4.649B |
December 31, 2015 | 2.330B |
September 30, 2015 | 4.430B |
June 30, 2015 | 4.557B |
March 31, 2015 | 2.659B |
December 31, 2014 | 2.501B |
September 30, 2014 | 7.866B |
June 30, 2014 | 2.517B |
March 31, 2014 | 4.705B |
December 31, 2013 | 2.486B |
September 30, 2013 | 3.179B |
June 30, 2013 | 3.222B |
March 31, 2013 | 2.701B |
December 31, 2012 | 2.694B |
September 30, 2012 | 3.863B |
June 30, 2012 | 2.473B |
March 31, 2012 | 6.256B |
December 31, 2011 | 3.057B |
September 30, 2011 | 5.764B |
Cash and Short Term Investments Definition
Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
4.789B
Minimum
Jun 2019
18.24B
Maximum
Sep 2020
9.198B
Average
8.762B
Median
Dec 2021
Cash and Short Term Investments (Quarterly) Benchmarks
Affimed NV | 80.58M |
InflaRx NV | 99.79M |
MorphoSys AG | 754.72M |
BioNTech SE | 18.29B |
Immatics NV | 470.78M |